FEROZ Pharmaceuticals: Major
Health Technology
Mkt Cap
16.2B
P/E (TTM)
17.23
EPS
17.86
ROE
7.50%
Div Yield
1.07%
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Return on Equity (ROE) | 6.58% | 7.14% | 3.46% | 9.64% | 16.89% | |
| Return on Assets (ROA) | 3.31% | 3.54% | 1.77% | 5.65% | 11.20% | |
| Return on Invested Capital | 5.73% | 5.98% | 2.85% | 8.28% | 15.70% | |
| Gross Margin | 40.45% | 39.13% | 35.84% | 40.77% | 39.11% | |
| Operating Margin | 10.18% | 9.90% | 7.18% | 13.21% | 16.32% | |
| EBITDA Margin | 15.13% | 13.30% | 11.31% | 17.72% | 20.80% | |
| Net Margin | 4.12% | 4.31% | 2.37% | 7.87% | 13.22% | |
| Pre-Tax Margin | 8.09% | 6.98% | 2.63% | 13.26% | 17.64% | |
| Liquidity | ||||||
| Current Ratio | 1.94 | 1.61 | 1.55 | 2.29 | 2.81 | |
| Quick Ratio | 0.89 | 0.77 | 0.59 | 1.31 | 1.95 | |
| Leverage | ||||||
| Debt / Equity | 0.35 | 0.44 | 0.44 | 0.28 | 0.15 | |
| Debt / Assets | 0.17 | 0.22 | 0.21 | 0.16 | 0.10 | |
| LT Debt / Equity | 0.13 | 0.16 | 0.23 | 0.20 | 0.13 | |
| LT Debt / Assets | 0.07 | 0.08 | 0.11 | 0.11 | 0.08 | |
| Net Debt | 1.87B | 3.74B | 2.35B | -280.90M | -1.63B | |
| Total Debt | 4.29B | 4.92B | 3.48B | 2.17B | 1.14B | |
| Efficiency | ||||||
| Asset Turnover | 0.80 | 0.82 | 0.75 | 0.72 | 0.85 | |
| Inventory Turnover | 1.86 | 1.86 | 1.71 | 2.03 | 2.51 | |
| Per Share | ||||||
| Book Value Per Share | 284.69 | 258.31 | 182.16 | 178.70 | 171.92 | |
| Tangible Book Per Share | 284.05 | 257.36 | 182.12 | 178.67 | 171.91 | |
| Cash Per Share | 55.74 | 27.04 | 26.05 | 56.41 | 63.75 | |
| Total Debt Per Share | 98.74 | 113.18 | 80.10 | 49.95 | 26.19 | |
| Working Capital Per Share | 143.69 | 85.08 | 69.97 | 100.47 | 104.72 | |
| Shares & Market | ||||||
| Total Shares Outstanding | 43,469,052 | 43,469,052 | 43,469,052 | 43,469,069 | 43,469,069 | |
| Market Cap | 16.94B | 10.84B | 5.95B | 9.74B | 12.78B | |
| Enterprise Value | 20.90B | 15.18B | 8.74B | 9.99B | 11.57B | |
| Employees | 1,556 | 1,485 | 1,680 | 1,545 | 1,252 | |
| Shareholders | 4,739 | 4,739 | 4,739 | 4,739 | 4,739 | |